Fruquintinib in refractory metastatic colorectal cancer: a multicenter real-world study ( vol 9, 103702, 2024)

被引：0

作者：

Xu, D. ^{[1
]}

Zeng, S. ^{[2
]}

Qiu, W. ^{[3
]}

Wang, G. ^{[4
]}

Qin, Z. ^{[5
]}

Liu, Y. ^{[1
]}

Zhou, S. ^{[1
]}

Zhang, Z. ^{[1
]}

Chang, W. ^{[1
,6
,7
]}

Feng, Q. ^{[1
,7
]}

Xu, J. ^{[1
,7
]}

机构：

[1] Fudan Univ, Zhongshan Hosp, Dept Colorectal Surg, Fenglin Rd 180, Shanghai, Peoples R China

[2] Cent South Univ, Xiangya Hosp, Dept Oncol, Changsha, Peoples R China

[3] Qingdao Univ, Affiliated Hosp, Dept Med Oncol, Qingdao, Peoples R China

[4] Hebei Med Univ, Hosp 2, Dept Gen Surg, Shijiazhuang, Peoples R China

[5] Zhejiang Prov Peoples Hosp, Hangzhou Med Coll, Peoples Hosp, Dept Oncol Ctr,Oncol, Hangzhou, Peoples R China

[6] Fudan Univ, Zhongshan Hosp, Dept Gen Surg, Xiamen Branch, Xiamen, Peoples R China

[7] Shanghai Engn Res Ctr Colorectal Canc Minimally In, Shanghai, Peoples R China

来源：

关键词：

D O I：

10.1016/j.esmoop.2024.104124

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：1